Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Patient safety

FDA insists on warning labels for OTC chlorhexidine products

The US Food and Drug Administration (FDA) has told manufacturers of over-the-counter (OTC) antiseptic products that contain chlorhexidine gluconate to add warning labels to their products about the possibility of a serious but rare allergic reaction.

The advice from the US medicines safety regulator comes after it identified 52 cases of anaphylaxis — including two deaths — associated with chlorhexidine products being applied to the skin. The cases, which occurred between 1969 and 2015, were all serious and 26 were life threatening. They were discovered following a trawl though national adverse event reporting system databases and the medical literature.

Chlorhexidine gluconate is mainly available over the counter in products used to clean and prepare the skin before surgery and injections to reduce bacteria that can trigger skin infections. Products are typically available as solutions, washes, sponges and swabs. Chlorhexidine gluconate is also available as a mouthwash to treat gingivitis or periodontal disease.

Warnings about the possibility of serious side effects are already included in patient information for prescription medicines containing chlorhexidine gluconate.

The FDA says healthcare professionals should ask patients if they have ever had an allergic reaction to any antiseptic before recommending or prescribing a chlorhexidine gluconate product. It says alternative products, including those containing povidone-iodine, alcohols, benzalkonium chloride, benzethonium chloride or parachlorometaxylenol, can be used if previous allergy to chlorhexidine gluconate is documented or suspected.

 

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2017.20202304

Readers' comments (1)

  • This is important, and news to me indeed. We v frequently use chlorhexidine even for infants; though in such cases allergy history inquisition is likely of no help, we yet thus ought to be more cautious.
    Dr Hana Fayyad, pediatrician

    Unsuitable or offensive? Report this comment

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • anaphylaxis skin reaction

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.